The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Open accessAbstract
Autoreactive memory T lymphocytes are implicated in the pathogenesis of autoimmune diseases. Here we demonstrate that disease-associated autoreactive T cells from patients with type-1 diabetes mellitus or rheumatoid arthritis (RA) are mainly CD4+CCR7−CD45RA−effector memory T cells (T EM cells) with elevated Kv1.3 potassium channel expression. In contrast, T cells with other antigen specificities from these patients, or autoreactive T cells from healthy individuals and disease controls, express low levels of Kv1.3 and are predominantly naïve or central-memory (T CM) cells. In T EM cells, Kv1.3 traffics to the immunological synapse during antigen presentation where it colocalizes with Kvβ2, SAP97, ZIP, p56 lck, and CD4. Although Kv1.3 inhibitors [ShK(L5)-amide (SL5) and PAP1] do not prevent immunological synapse formation, they suppress Ca 2+-signaling, cytokine production, and proliferation of autoantigen-specific T EM cells at pharmacologically relevant concentrations while sparing other classes of T cells. Kv1.3 inhibitors ameliorate pristane-induced arthritis in rats and reduce the incidence of experimental autoimmune diabetes in diabetes-prone (DP-BB/W) rats. Repeated dosing with Kv1.3 inhibitors in rats has not revealed systemic toxicity. Further development of Kv1.3 blockers for autoimmune disease therapy is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Kavey, R.-E. W., Daniels, S. R., Lauer, R. M., Atkins, D. L., Hayman, L. L., & Taubert, K. (2003) · Circulation · doi:10.1161/01.cir.0000061521.15730.6e · Cited by 821
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
DeCoursey, T. E., Chandy, K. G., Gupta, S., & Cahalan, M. D. (1984) · Nature · doi:10.1038/307465a0 · Cited by 744
Self-citationEffects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Heise, T., Nosek, L., Rønn, B. B., Endahl, L., Heinemann, L., Kapitza, C., & Draeger, E. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1614 · Cited by 614
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Self-citationSmyth, D., Cooper, J. D., Collins, J. E., Heward, J. M., Franklyn, J. A., Howson, J. M. M., Vella, A., Nutland, S., Rance, H. E., Maier, L., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3020 · Cited by 503
Continuous glucose monitoring and closed‐loop systems
Hovorka, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 443
K+ channels as targets for specific immunomodulation
George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.010 · Cited by 427
Self-citationThe voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
Self-citationShould minimal blood glucose variability become the gold standard of glycemic control?
Hirsch, I. B., & Brownlee, M. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.10.001 · Cited by 405
Vella, A., Cooper, J. D., Lowe, C. E., Walker, N., Nutland, S., Widmer, B., Jones, R., Ring, S. M., McArdle, W., Pembrey, M. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429843 · Cited by 352
Beeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Self-citationVague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294
Bresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
Gomez-Reino, J. J., Carmona, L., & the BIOBADASER Group (2006) · Arthritis Research & Therapy · doi:10.1186/ar1881 · Cited by 289
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
Pinkse, G. G. M., Tysma, O. H. M., Bergen, C. A. M., Kester, M. G. D., Ossendorp, F., van Veelen, P. A., Keymeulen, B., Pipeleers, D., Drijfhout, J. W., & Roep, B. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508621102 · Cited by 276
Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe
Soedamah-Muthu, S. S., Chaturvedi, N., Toeller, M., Ferriss, B., Reboldi, P., Michel, G., Manes, C., Fuller, J. H., & the EURODIAB Prospective Complications Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.2.530 · Cited by 251
Beeton, C., Pennington, M. W., Wulff, H., Singh, S., Nugent, D., Crossley, G., Khaytin, I., Calabresi, P. A., Chen, C.-Y., Gutman, G. A., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008193 · Cited by 249
Self-citationCD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12516 · Cited by 243
Schmitz, A., Sankaranarayanan, A., Azam, P., Schmidt-Lassen, K., Homerick, D., Hänsel, W., & Wulff, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015669 · Cited by 226
Self-citationRemapping the Insulin Gene/IDDM2 Locus in Type 1 Diabetes
Barratt, B. J., Payne, F., Lowe, C. E., Hermann, R., Healy, B. C., Harold, D., Concannon, P., Gharani, N., McCarthy, M. I., Olavesen, M. G., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1884 · Cited by 223
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus
Rother, K. I., & Harlan, D. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423235 · Cited by 220
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo
Koo, G. C., Blake, J. T., Talento, A., Nguyen, M., Lin, S., Sirotina, A., Shah, K., Mulvany, K., Hora, D., Cunningham, P., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5120 · Cited by 219
Cucca, F. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2025 · Cited by 188
Rus, H., Pardo, C. A., Hu, L., Darrah, E., Cudrici, C., Niculescu, T., Niculescu, F., Mullen, K. M., Allie, R., Guo, L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501770102 · Cited by 184
Self-citationGAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Viglietta, V., Kent, S. C., Orban, T., & Hafler, D. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14114 · Cited by 170
Subset-Specific Expression of Potassium Channels in Developing Murine T Lymphocytes
Lewis, R. S., & Cahalan, M. D. (1988) · Science · doi:10.1126/science.2448877 · Cited by 165
Amin, R., Turner, C., Aken, S. V., Bahu, T. K., Watts, A., Lindsell, D. R., Dalton, R. N., & Dunger, D. B. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00590.x · Cited by 150
Bangstad, H. ‐., Dahl‐Jørgensen, K., Hanssen, K. F., Østerby, R., Berg, K. J., & Hartmann, A. (1994) · Diabetologia · doi:10.1007/s001250050136 · Cited by 145
Panyi, G., Vámosi, G., Bacsó, Z., Bagdány, M., Bodnár, A., Varga, Z., Gáspár, R., Mátyus, L., & Damjanovich, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307421100 · Cited by 134
The renal hemodynamic basis of diabetic nephropathy.
Gt, O., & Hostetter, T. H. (1997) · PubMed · Cited by 128
Current indications for pancreas or islet transplant
Ryan, E. A., Bigam, D. L., & Shapiro, A. M. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00460.x · Cited by 114
Potassium Channels, Memory T Cells, and Multiple Sclerosis
Beeton, C., & Chandy, K. G. (2005) · The Neuroscientist · doi:10.1177/1073858405278016 · Cited by 110
Self-citationGastrulation in the mouse embryo: Ultrastructural and molecular aspects of germ layer morphogenesis
Tam, P., Williams, E. A., & Chan, W. Y. (1993) · Microscopy Research and Technique · doi:10.1002/jemt.1070260405 · Cited by 107
Gottlieb, A. B., Casale, T. B., Frankel, E., Goffe, B. S., Lowe, N. J., Ochs, H. D., Roberts, J. L., Washenik, K., Vaishnaw, A. K., & Gordon, K. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01836-x · Cited by 86
Klareskog, L., Gaubitz, M., Rodrı́guez-Valverde, V., Malaise, M., Dougados, M., & Wajdula, J. S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038349 · Cited by 84
Renal Enlargement Precedes Renal Hyperfiltration in Early Experimental Diabetes in Rats
Bak, M., Thomsen, K., Christiansen, T., & Flyvbjerg, A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171287 · Cited by 81
Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant
Sadelain, M., Qin, H.-Y., SUMOSKI, W., Parfrey, N. A., Singh, B., & Rabinovitch, A. (1990) · Journal of Autoimmunity · doi:10.1016/s0896-8411(05)80034-4 · Cited by 77
Li, Y., Wang, P., Xu, J., & Désir, G. V. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00091.2005 · Cited by 73
Self-citationDiabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic.
Like, A. A., Guberski, D. L., & Butler, L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3254 · Cited by 72
Calafiore, R. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.201 · Cited by 70
Lange, F., Bajtner, E., Rintisch, C., Nandakumar, K. S., Sack, U., & Holmdahl, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026120 · Cited by 65
Goffe, B. S., Papp, K. A., Gratton, D., Krueger, G. G., Darif, M., Lee, S., Bozic, C. M., Sweetser, M. T., & Ticho, B. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.12.007 · Cited by 62
Awata, T., Guberski, D. L., & Like, A. A. (1995) · Endocrinology · doi:10.1210/en.136.12.5731 · Cited by 60
ACE-I and ARBs in early diabetic nephropathy
Mauer, M. S., Zinman, B., GARDINER, R. J., Drummond, K. N., Suissa, S., Donnelly, S. M., Strand, T. D., Kramer, M. S., Klein, R., & Sinaiko, A. R. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.048 · Cited by 58
Human embryonic stem cells: Possibilities for human cell transplantation
Liew, C.-G., Moore, H. D. M., Ruban, L., Shah, N., Cosgrove, K. E., Dunne, M. J., & Andrews, P. W. (2005) · Annals of Medicine · doi:10.1080/07853890500379463 · Cited by 52
Ishida, Y., & Chused, T. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.610 · Cited by 48
Reichard, P., Britz, A. E., Carlsson, P., CARS, I., Lindblad, L. E., Nilsson, B., & Rosenqvist, U. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00271.x · Cited by 48
Herzyk, D. J., Gore, E. R., Polsky, R., Nadwodny, K. L., Maier, C. C., Liu, S., Hart, T. K., Harmsen, A. G., & Bugelski, P. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1032-1043.2001 · Cited by 47
Szigligeti, P., Neumeier, L., Duke, E., Chougnet, C. A., Takimoto, K., Lee, S. M., Filipovich, A. H., & Conforti, L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109967 · Cited by 45
Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells
Mallone, R., Kochik, S. A., Laughlin, E. M., Gersuk, V. H., Reijonen, H., Kwok, W. W., & Nepom, G. T. (2004) · Diabetes · doi:10.2337/diabetes.53.4.971 · Cited by 44
Self-citationRinaldi, L. (2006) · Brain · doi:10.1093/brain/awl179 · Cited by 43
Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus
Naik, R. G., Beckers, C., Wentwoord, R. A. R., Frenken, A., Duinkerken, G., Brooks‐Worrell, B., Schloot, N. C., Palmer, J. P., & Roep, B. O. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.04.002 · Cited by 28
Beck, J. C., Goodner, C. J., Wilson, C., Wilson, D., Glidden, D. V., Baskin, D. G., Lernmark, Å., & Braquet, P. G. (1991) · Autoimmunity · doi:10.3109/08916939109007648 · Cited by 25
Esamai, F. (2004) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmh069 · Cited by 14
Vieira, J. L. F., & Mı́dio, A. F. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200112000-00003 · Cited by 12
Ellerman, K. E., & LIKE, A. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.923 · Cited by 8
Cited by
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Voltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 799
Self-citationIon Channels in Innate and Adaptive Immunity
Feske, S., Wulff, H., & Skolnik, E. Y. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112212 · Cited by 768
Self-citationSynthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Molecular Basis of Calcium Signaling in Lymphocytes: STIM and ORAI
Hogan, P. G., Lewis, R. S., & Rao, A. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132550 · Cited by 760
Metadata
- Authors
- Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., Wang, P. H., LeeHealey, C. J., S. Andrews, B., Sankaranarayanan, A., Homerick, D., Roeck, W. W., Tehranzadeh, J., Stanhope, K. L., Zimin, P., Havel, P. J., Griffey, S., Knaus, H.-G., Nepom, G. T., Gutman, G. A., Calabresi, P. A., & Chandy, K. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-11-14
- Volume
- 103
- Issue
- 46
- Pages
- 17414-17419
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2019310318
- Cited by
- 538
- References
- 65
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.